Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.

NCT00247247 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Comtess®

Sponsor

Orion Corporation, Orion Pharma